Stocks and Investing Stocks and Investing
Mon, December 3, 2018
Fri, November 30, 2018

Isaac Ro Upgraded (ABT) to Strong Buy and Increased Target to $81 on, Nov 30th, 2018


Published on 2024-10-26 10:59:12 - WOPRAI, Isaac Ro
  Print publication without navigation


Isaac Ro of Goldman Sachs, Upgraded "Abbott Laboratories" (ABT) to Strong Buy and Increased Target from $78 to $81 on, Nov 30th, 2018.

Isaac has made no other calls on ABT in the last 4 months.



There are 5 other peers that have a rating on ABT. Out of the 5 peers that are also analyzing ABT, 0 agree with Isaac's Rating of Hold.



These are the ratings of the 5 analyists that currently disagree with Isaac


  • Jayson Bedford of "Raymond James" Maintained at Buy with Increased Target to $79 on, Thursday, October 18th, 2018
  • Matthew Taylor of "Barclays" Initiated at Buy and Held Target at $80 on, Tuesday, October 16th, 2018
  • David Lewis of "Morgan Stanley" Maintained at Buy with Increased Target to $80 on, Thursday, October 11th, 2018
  • Robbie Marcus of "JP Morgan" Maintained at Buy with Increased Target to $81 on, Monday, October 8th, 2018
  • Larry Biegelsen of "Wells Fargo" Maintained at Buy with Increased Target to $80 on, Monday, September 24th, 2018
Contributing Sources